Dynavax Technologies Corp

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$15.50

+0.00 (+0.00%)

As of Aug 1, 1:35 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target -10.3% upside

Low Target $9.87

Average Target $13.91

High Target $23.13

Current Price $15.50

Current
$15.50

Target
$13.91

$9.87 $13.91 avg $23.13

Scenario Analysis

Bear Case

$9.87

-36.3%

Low target

Base Case

$13.91

-10.3%

Avg target

Bull Case

$23.13

+49.2%

High target

Risk/Reward

1.4x

Balanced

Price in Context

52-Week High

$15.73

-1.5% from high

52-Week Low

$9.20

+68.5% from low

Target vs 52W High

$13.91

-11.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%